We noticed you are on our US page. Want to switch regions? Choose from the options:

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.

Written by

Tripathy Debu, Brufsky Adam, Cobleigh Melody, Kaufman Peter A, Mason Ginny, O’Shaughnessy Joyce, Rugo Hope S, Swain Sandra M, Yardley Denise A, Chu Laura, Li Haocheng, Antao Vincent, Hurvitz Sara A